Cleared Traditional

K180888 - LYFT

K180888 is the FDA 510(k) clearance for LYFT by Uplevity, Inc.. It is a Class 2 General & Plastic Surgery device (product code OLP) cleared through the Traditional 510(k) pathway after a 148-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2018
Decision
148d
Days
Class 2
Risk

K180888 is an FDA 510(k) clearance for the LYFT. Classified as Over-the-counter Powered Light Based Laser For Acne (product code OLP), Class II - Special Controls.

Submitted by Uplevity, Inc. (Niantic, US). The FDA issued a Cleared decision on August 30, 2018 after a review of 148 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Uplevity, Inc. devices

Submission Details

510(k) Number K180888 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 04, 2018
Decision Date August 30, 2018
Days to Decision 148 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
33d slower than avg
Panel avg: 115d · This submission: 148d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OLP Over-the-counter Powered Light Based Laser For Acne
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition The Device Is Intended For Over-the-counter (otc) Use To Treat Patients With Mild To Moderate Acne Vulgaris. The Device Is Intended To Emit Energy In The Red And Blue Region Of The Spectrum, Specifically Indicated To Treat Mild To Moderate Acne Vulgaris.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Contract In-House Counsel and Consultants, LLC
Marc C. Sanchez

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OLP Over-the-counter Powered Light Based Laser For Acne

All 25
Devices cleared under the same product code (OLP) and FDA review panel - the closest regulatory comparables to K180888.
PDT-FACE
K192295 · Beijing Adss Development Co., Ltd. · May 2020
Poly Clear
K183708 · Medtek Skincare, LLC · Sep 2019
dpl SpotLite
K183118 · Led Technologies, Inc. · Feb 2019
LED Light Therapy Device
K180900 · Uvbiotek, LLC · Jul 2018
Neutrogena Light Therapy Acne Mask+
K180847 · Johnson & Johnson Consumer, Inc. · Jun 2018
reVive Light Therapy LED Cleansing System
K180447 · Led Technologies, Inc. · Jun 2018